Highlights BINEX Co., Ltd.

Equities

A053030

KR7053030003

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-07-15 EDT			5-day change	1st Jan Change
19,400 ^KRW	-5.37%		-2.27%	+116.76%

03-15	BINEX Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-05	Singapore Stocks Linger in Red; IX Biopharma's Shares Soar 12% Following Unveiling of Novel Drug Delivery System	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BINEX Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-15	CI
Sinjia Land Terminates Loan Deal With BINEX; Shares Up 6%	03-04	MT
Sinjia Land Scraps Deal to Buy Alternative Fuels Firm Over Unmet Closing Condition	01-01	MT
BINEX Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI
Sinjia Land Extends Long Stop Date to Acquire BINEX Singapore	22-09-29	MT
Sinjia Land to Make Refundable Deposit to BINEX in Relation to RTO Deal	22-06-24	MT
Sinjia Land to Acquire BINEX Singapore in RTO Deal	22-02-01	MT
With Investment Co., Ltd. acquired the remaining 16.63% stake in Rhinos Asset Management Co., Ltd from BINEX Co., Ltd..	21-09-30	CI
Exclusive: South Korea's GL Rapha to ship out 10 million Sputnik Light COVID-19 shots this month	21-09-14	RE
Boryung Pharmaceutical : S.Korea's GL Rapha to ship out 10 mln Sputnik Light COVID-19 shots this month	21-09-14	RE
Tranche Update on BINEX Co., Ltd.'s Equity Buyback Plan announced on August 23, 2021.	21-09-03	CI
BINEX Co., Ltd.'s Equity Buyback announced on August 23, 2021, has closed with 283,286 shares, representing 0.91% for KRW 5,532.99 million.	21-08-30	CI
BINEX Co., Ltd. announces an Equity Buyback for 283,286 shares.	21-08-22	CI
BINEX Co., Ltd. authorizes a Buyback Plan.	21-08-22	CI
An unknown buyer cancelled the acquisition of 6.97% stake in PeproMene Bio. Inc. from BINEX Co., Ltd..	21-05-10	CI
PharmAbcine Signs CMO Contract with Binex	20-09-02	CI
PharmAbcine Signs Long-Term Contract Manufacturing Organization Agreement for Olinvacimab with Binex	20-06-26	CI
GenoFocus, Inc. to Enter into Co-Development Agreement with Eight Organizations for COVID-19	20-06-02	CI
An unknown buyer agreed to acquire 6.97% stake in PeproMene Bio. Inc. from BINEX Co., Ltd. for KRW 9.8 billion.	20-05-13	CI
Genexine, Inc. and Binex Co. Ltd. Enter into Co-Development Partnership	20-03-17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BINEX Co., Ltd.

Equities

A053030

KR7053030003

Highlights

Filters